These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38095900)

  • 1. Alcohol Intake Thresholds Among Individuals With Steatotic Liver Disease.
    Yeo YH; Zhu Y; Arab JP; Ni W; Xu X; Shi J; Li J
    JAMA Netw Open; 2023 Dec; 6(12):e2347548. PubMed ID: 38095900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
    Israelsen M; Torp N; Johansen S; Hansen CD; Hansen ED; Thorhauge K; Hansen JK; Villesen I; Bech K; Wernberg C; Andersen P; Lindvig KP; Tsochatzis EA; Thiele M; Rinella ME; Krag A;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):218-228. PubMed ID: 38218202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among US Veterans With Steatotic Liver Disease.
    Wong RJ; Yang Z; Cheung R; Singal AK; Do A; Ahmed A; Yeoh A
    Gastroenterology; 2024 Jun; 166(6):1156-1165.e4. PubMed ID: 38428619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake.
    Wu Y; Fang F
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):409. PubMed ID: 38604196
    [No Abstract]   [Full Text] [Related]  

  • 5. Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake - Authors' reply.
    Israelsen M; Rinella ME; Krag A
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):409-410. PubMed ID: 38604197
    [No Abstract]   [Full Text] [Related]  

  • 6. Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis.
    Mori K; Akiyama Y; Tanaka M; Sato T; Endo K; Hosaka I; Hanawa N; Sakamoto N; Furuhashi M
    J Gastroenterol Hepatol; 2024 Jul; 39(7):1382-1393. PubMed ID: 38629681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.
    Marti-Aguado D; Calleja JL; Vilar-Gomez E; Iruzubieta P; Rodríguez-Duque JC; Del Barrio M; Puchades L; Rivera-Esteban J; Perelló C; Puente A; Gomez-Medina C; Escudero-García D; Serra MA; Bataller R; Crespo J; Arias-Loste MT
    J Hepatol; 2024 Jul; ():. PubMed ID: 38971533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Hansen CD; Lindvig KP; Grønbæk H; Gluud LL; Thiele M; Krag A
    Ugeskr Laeger; 2024 May; 186(19):. PubMed ID: 38808766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.
    Åberg F; Puukka P; Salomaa V; Männistö S; Lundqvist A; Valsta L; Perola M; Färkkilä M; Jula A
    Hepatology; 2020 Mar; 71(3):835-848. PubMed ID: 31323122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Change of Alcohol Use is a Dynamic Contributor to Steatotic Liver Disease Progression.
    Lee BP; Louvet A
    Gastroenterology; 2024 Jun; 166(6):965-967. PubMed ID: 38555072
    [No Abstract]   [Full Text] [Related]  

  • 11. Steatotic liver disease phenotypes in the United States: The impact of alcohol consumption assessment.
    Ciardullo S; Perseghin G
    J Hepatol; 2024 May; 80(5):e203-e204. PubMed ID: 37813242
    [No Abstract]   [Full Text] [Related]  

  • 12. Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks.
    Martínez-Urbistondo D; Perez-Diaz-Del-Campo N; Landecho MF; Martínez JA
    Curr Obes Rep; 2024 Sep; 13(3):461-474. PubMed ID: 38520634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
    Canivet CM; Boursier J; Loomba R
    Semin Liver Dis; 2024 Feb; 44(1):35-42. PubMed ID: 38531378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of past and present alcohol use in steatotic liver disease.
    Åberg F
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):188-189. PubMed ID: 38218201
    [No Abstract]   [Full Text] [Related]  

  • 15. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up.
    Choe HJ; Moon JH; Kim W; Koo BK; Cho NH
    Metabolism; 2024 Apr; 153():155800. PubMed ID: 38266957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity.
    Kim GA; Moon JH; Kim W
    Clin Mol Hepatol; 2023 Oct; 29(4):831-843. PubMed ID: 37634892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption.
    Iwasa M; Sugimoto R; Eguchi A; Tamai Y; Shigefuku R; Fujiwara N; Tanaka H; Kobayashi Y; Ikoma J; Kaito M; Nakagawa H
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):793-801. PubMed ID: 38526942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019-2021.
    Kang DE; Oh SN
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020.
    Kalligeros M; Vassilopoulos A; Vassilopoulos S; Victor DW; Mylonakis E; Noureddin M
    Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1330-1332.e4. PubMed ID: 37949334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adults.
    Tajima R; Imamura F; Kimura T; Kobayashi S; Masuda K; Iida K
    Clin Nutr; 2020 May; 39(5):1580-1586. PubMed ID: 31427182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.